As an individual who has dedicated years to researching and addressing viral threats, I am deeply troubled by the lack of preparedness we currently face. With significant reductions in funding for medical science, particularly in the realms of global health, research, and surveillance, we are left vulnerable to emerging threats.
The devastating impact of HIV on global health serves as a stark reminder of how a single virus can reshape the course of humanity. When I proposed in 1982 at the National Cancer Institute that a retrovirus could be the culprit behind AIDS, many in the scientific community were skeptical. Despite our recent discoveries of human retroviruses like HTLV-1 and HTLV-2, there was a prevailing belief in high-income countries that infectious diseases were a thing of the past. This false sense of security led to the closure of infectious disease departments and a decline in specialized training just as a new global health crisis was unfolding.
However, our relentless pursuit of the truth and unwavering commitment to research led to a rapid resurgence in funding and interest in virology, immunology, and public health as the AIDS pandemic spread. The co-discovery of HIV as the cause of AIDS and the subsequent development of the HIV blood test and life-saving treatments were the result of sustained research, infrastructure, and global scientific collaboration.
As philanthropist Mary Lasker famously said, “If you think research is expensive, try disease.” This statement encapsulates the importance of continued investment in scientific research to combat emerging threats effectively.
Currently, the emergence of H5N1 avian influenza poses a significant risk, with a concerning trend of declining investment in global health surveillance and research. The virus, once primarily affecting birds, has now infected mammals and humans, leading to widespread culling of poultry and human infections. While the virus has not yet mutated to transmit from human to human, stronger surveillance at the human-animal interface is crucial.
Efforts such as genomic monitoring and data sharing are essential to track and understand the virus’s behavior. Despite recent investments in biosecurity, relief, and vaccine development, more needs to be done to combat the threat of H5N1. The power of mRNA vaccines in the fight against COVID-19 underscores the potential of modern medicine, but we must overcome skepticism and ensure clear communication and transparency in scientific endeavors.
It is imperative to strengthen global virology expertise and health systems to effectively respond to future threats. The economic toll of early missteps in the COVID-19 pandemic serves as a stark reminder of the importance of proactive measures and sustained investment in research and preparedness.
In conclusion, innovation and progress in combating viral threats require years of foundational research and unwavering support. Science alone cannot address these challenges; it needs continuous investment, collaboration, and trust to succeed. The lessons learned from past pandemics should serve as a call to action to act now and not wait for the next outbreak to be in full swing.
Robert C. Gallo, a co-founder of the Global Virus Network and a professor at the University of South Florida, is renowned for his groundbreaking discoveries in the field of virology and his contributions to HIV research.
